Daiwa Securities Group
RUBY

Daiwa Securities Group’s Rubius Therapeutics, Inc RUBY Stock Holding History

Daiwa Securities Group’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-307
Closed – – 1425
2022
Q3 		$0 Hold
307
– – ﹤0.01% 1432
2022
Q2 		$0 Hold
307
– – ﹤0.01% 1465
2022
Q1 		$2K Hold
307
– – ﹤0.01% 1281
2021
Q4 		$3K Hold
307
– – ﹤0.01% 1264
2021
Q3 		$5K Buy
307
+129
+72% +$2.81K ﹤0.01% 1184
2021
Q2 		$4K Hold
178
– – ﹤0.01% 1099
2021
Q1 		$5K Hold
178
– – ﹤0.01% 1083
2020
Q4 		$1K Sell
178
-272
-60% -$1.62K ﹤0.01% 1238
2020
Q3 		$2K Hold
450
– – ﹤0.01% 1153
2020
Q2 		$2K Hold
450
– – ﹤0.01% 1173
2020
Q1 		$2K Hold
450
– – ﹤0.01% 1175
2019
Q4 		$4K Sell
450
-53
-11% -$513 ﹤0.01% 1138
2019
Q3 		$4K Hold
503
– – ﹤0.01% 1099
2019
Q2 		$8K Hold
503
– – ﹤0.01% 1069
2019
Q1 		$9K Sell
503
-134
-21% -$2.06K ﹤0.01% 1041
2018
Q4 		$10K Buy
+637
New +$11.6K ﹤0.01% 1000

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Daiwa Securities Group's RUBY Position: Q4 2022 in Review

Daiwa Securities Group sold out of Rubius Therapeutics, Inc (RUBY) in Q4 2022, closing a stake of 307 shares.

Daiwa Securities Group first reported a position in RUBY in Q4 2018 and held it in 16 quarters. The position peaked at $10K in Q4 2018. 42 funds tracked by Wall St. Rank hold RUBY as of Q4 2022.

  • Daiwa Securities Group reported no remaining Rubius Therapeutics, Inc position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 307 Rubius Therapeutics, Inc shares in Q4 2022.
  • Daiwa Securities Group first reported a position in Rubius Therapeutics, Inc in Q4 2018 and held it in 16 quarters.
  • Daiwa Securities Group's Rubius Therapeutics, Inc position peaked at $10K in Q4 2018.
  • 42 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.